| Condition or disease | Intervention/treatment |
|---|---|
| Echocardiography | Other: Education |
Show detailed description
| Study Type : | Observational |
| Actual Enrollment : | 5000 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | REASON 2 Trial - Timing For Single View Bedside Cardiac Ultrasound |
| Actual Study Start Date : | June 1, 2019 |
| Actual Primary Completion Date : | December 31, 2019 |
| Actual Study Completion Date : | March 2, 2020 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Sub-xyphoid
Ultrasound views of the heart obtained using the sub-typhoid approach. Individuals with a mix of co-morbidities but are clinically stable will be viewed. Physicians with experience in bedside ultrasound are being studied.
|
Other: Education
Physicians will undergo training on how to rapidly obtain appropriate images.
|
|
Para-sternal Long
Ultrasound views of the heart obtained using the parasternal long approach. Individuals with a mix of co-morbidities but are clinically stable will be viewed. Physicians with experience in bedside ultrasound are being studied.
|
Other: Education
Physicians will undergo training on how to rapidly obtain appropriate images.
|
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
Exclusion Criteria:
| United States, Massachusetts | |
| UMASS Memorial Medical Center | |
| Worcester, Massachusetts, United States, 01655 | |
| Principal Investigator: | Romolo Gaspari, MD. PhD | UMASS Medical School |
| Tracking Information | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| First Submitted Date | April 22, 2019 | ||||||||||||||||
| First Posted Date | April 25, 2019 | ||||||||||||||||
| Last Update Posted Date | April 16, 2020 | ||||||||||||||||
| Actual Study Start Date | June 1, 2019 | ||||||||||||||||
| Actual Primary Completion Date | December 31, 2019 (Final data collection date for primary outcome measure) | ||||||||||||||||
| Current Primary Outcome Measures |
Timing of Ultrasound Imaging [ Time Frame: 10 seconds ] Number of seconds from start to finish of the ultrasound imaging
|
||||||||||||||||
| Original Primary Outcome Measures | Same as current | ||||||||||||||||
| Change History | |||||||||||||||||
| Current Secondary Outcome Measures |
Quality of Ultrasound Imaging [ Time Frame: 5 seconds ] The quality of the ultrasound images based on an ordinal numeric scale of image quality. Minimum =1 and maximum =5. Higher numbers equal better imaging quality. There is no subscale.
|
||||||||||||||||
| Original Secondary Outcome Measures |
Quality of Ultrasound Imaging [ Time Frame: 5 seconds ] The quality of the ultrasound images based on a numeric scale of image quality
|
||||||||||||||||
| Current Other Pre-specified Outcome Measures | Not Provided | ||||||||||||||||
| Original Other Pre-specified Outcome Measures | Not Provided | ||||||||||||||||
| Descriptive Information | |||||||||||||||||
| Brief Title | Timing For Single View Bedside Cardiac Ultrasound | ||||||||||||||||
| Official Title | REASON 2 Trial - Timing For Single View Bedside Cardiac Ultrasound | ||||||||||||||||
| Brief Summary | The goal of this study is to measure the hypothetical minimal amount of time it takes to perform a single view bedside trans-thoracic echo (TTE) comparing sub-xyphoid view and the parasternal long view. Physicians will be timed from initiation of imaging to completion of the recording of a single view of the heart. Images will be rated for quality. | ||||||||||||||||
| Detailed Description |
This is a multi-center, prospective, observational trial involving sites across the United States and Canada. Residents will be enrolled when performing ultrasound imaging on non-critically ill patients in the emergency department. Residents obtaining cardiac ultrasound images on patients in the emergency department during pre-planned educational sessions will be enrolled in a prospective manner. Physicians participating in this study will undergo a short educational session on both techniques of cardiac ultrasound as well as rationale for performing cardiac ultrasound rapidly during cardiac arrest. This educational intervention will provide the cognitive framework for the physicians to participate in the study. Physicians will be told to obtain the images as fast as possible and to get good quality images but they will be able to stop imaging if they are unable to obtain the images rapidly. Individual physicians will be randomized to obtain a single parasternal or sub-xyphoid view of the hear first, followed by the other view. TTE will be performed on conscious and awake patients in the emergency department. Imaging will be performed in front of research staff. Primary outcome is time from transducer-skin contact to completion of the digital recording of a visible heart beating. Secondary outcome is the quality of the ultrasound image using a 5-point image quality scale. Patients who will be imaged in this study will be those patients that would have been imaged during the existing educational session (scan shift). The patient will not need consent but can be told about the study if needed. No patient will be imaged if they have the possibility of having a clinical deterioration during the ultrasound imaging. Each set of images (PSL and SX) will be from a unique patient. Subject data, with Protected Health Information (PHI) removed, will be recorded on data sheets prior to uploading into a centralized electronic database as soon as possible. Data will be obtained during the educational encounter including: Resident ID, post graduate year (PGY) level, Number of Cardiac Ultrasounds performed prior to starting study, US view attempted first, Imaging duration (seconds), Patient height, weight gender and age. The imaging protocol will be standardized for consistency of timing. Prior to the ultrasound imaging the patient and ultrasound machine will be positioned with the patient laying flat on their back with the ultrasound machine immediately next to the patient's stretcher. A numbered study identification number (ID) will be entered into the US machine instead of any actual patient identifiers. The patient will have the area of their chest and abdomen exposed where imaging will occur. No instructions will be given to the patient about the imaging other that to lay still and lay flat. The patient will not be told to take a deep breath or to hold their breath or to position themselves in any way. The study subject (i.e. physician) will stand to the left or right of the patient with the transducer in hand. Imaging will commence when directed by research staff. The study subject (i.e. physician) is instructed to obtain a specific view of the heart as rapidly as possible, with an end goal of obtaining a clear view of the heart as it contracts. The study subject is instructed to balance speed and imaging quality, but the predominant instruction is to get it a view of the heart beating as quickly as possible. The study subject will record a 4 second digital clip of the heart and remove the transducer from the patient's skin when they are done. Upon completing the imaging of the first view the images will be scored and the subject will prepare to be timed on the second view. The study subject (i.e. the physician) will be randomized to initially one of two views, PSL or SX. Ultrasound images will consist of a single recorded view, either subxyphoid or parasternal. The randomization will occur immediately prior to obtaining the images. Randomization will occur using binary randomization app on smart phone and this will be recorded on study sheet. The second view (whichever view was not done the first time) will be recorded immediately after the completion and recording of data from the first view. TIMING OF CARDIAC IMAGES Timing will occur using a standardized protocol. The subject will be told to start their imaging at the direction of research staff. The timing will start when the ultrasound transducer touches the patients skin.The timing will end when the transducer is removed from the patients skin for the last time. INTERPRETATION OF CARDIAC IMAGES Images will be rated for quality by both the subject and research staff immediately after image review. This will occur blinded to each other's rating. All ultrasound images will be recorded for later review. Ultrasound images will be rated using a 5 point imaging scale. Images will be blindly reviewed by research staff at UMASS later using the same 5 point imaging scale and categorization. Images will also be reviewed later for identification of specific cardiac landmarks including Mitral Valve, Aortic Valve, Left Ventricle and Right Ventricle. |
||||||||||||||||
| Study Type | Observational | ||||||||||||||||
| Study Design | Observational Model: Cohort Time Perspective: Prospective |
||||||||||||||||
| Target Follow-Up Duration | Not Provided | ||||||||||||||||
| Biospecimen | Not Provided | ||||||||||||||||
| Sampling Method | Non-Probability Sample | ||||||||||||||||
| Study Population | All physicians participating in existing ultrasound educational programs will be considered for enrollment. | ||||||||||||||||
| Condition | Echocardiography | ||||||||||||||||
| Intervention | Other: Education
Physicians will undergo training on how to rapidly obtain appropriate images.
|
||||||||||||||||
| Study Groups/Cohorts |
|
||||||||||||||||
| Publications * |
|
||||||||||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||||||||||
| Recruitment Information | |||||||||||||||||
| Recruitment Status | Completed | ||||||||||||||||
| Actual Enrollment |
5000 | ||||||||||||||||
| Original Estimated Enrollment |
2000 | ||||||||||||||||
| Actual Study Completion Date | March 2, 2020 | ||||||||||||||||
| Actual Primary Completion Date | December 31, 2019 (Final data collection date for primary outcome measure) | ||||||||||||||||
| Eligibility Criteria |
Inclusion Criteria:
Exclusion Criteria:
|
||||||||||||||||
| Sex/Gender |
|
||||||||||||||||
| Ages | Child, Adult, Older Adult | ||||||||||||||||
| Accepts Healthy Volunteers | Yes | ||||||||||||||||
| Contacts | Contact information is only displayed when the study is recruiting subjects | ||||||||||||||||
| Listed Location Countries | United States | ||||||||||||||||
| Removed Location Countries | |||||||||||||||||
| Administrative Information | |||||||||||||||||
| NCT Number | NCT03927755 | ||||||||||||||||
| Other Study ID Numbers | UMASS-ED-4-22-19 | ||||||||||||||||
| Has Data Monitoring Committee | No | ||||||||||||||||
| U.S. FDA-regulated Product |
|
||||||||||||||||
| IPD Sharing Statement |
|
||||||||||||||||
| Responsible Party | Romolo Gaspari, University of Massachusetts, Worcester | ||||||||||||||||
| Study Sponsor | University of Massachusetts, Worcester | ||||||||||||||||
| Collaborators | Not Provided | ||||||||||||||||
| Investigators |
|
||||||||||||||||
| PRS Account | University of Massachusetts, Worcester | ||||||||||||||||
| Verification Date | April 2020 | ||||||||||||||||